Efficacy ans safety of mepolizumab in hypereosinophilic syndrome: a Phase III, randomized, placebo-controlled trial

被引：0
|
作者：
Steinfeld, J. [1 ]
Roufosse, F. [2 ]
Kahn, J. E. [3 ]
Gleich, G. J. [4 ]
Rothenberg, M. E. [5 ,6 ]
Wardlaw, A. J. [7 ]
Kirby, S. Y. [8 ]
Gilson, M. [9 ]
Bentley, J. H. [10 ]
Bradford, E. S. [11 ]
Yancey, S. W. [11 ]
机构：
[1] Gsk, Resp Res & Dev, Collegeville, PA USA
[2] Univ Libre Bruxelles, Hop Erasme, Dept Internal Med, Brussels, Belgium
[3] Univ Versailles St Quentin En Yvelines, Hop Ambroise Pare, Dept Internal Med, Boulogne, France
[4] Univ Utah, Sch Med, Salt Lake City, UT USA
[5] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA
[6] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA
[7] Univ Leicester, Inst Lung Hlth, Leicester, Leics, England
[8] Gsk, Res Triangle Pk, NC USA
[9] Gsk, Resp Res & Dev, Stockley Pk, Uxbridge, Middx, England
[10] Gsk, Clin Stat, Stockley Pk, Uxbridge, Middx, England
[11] Gsk, Resp Therapeut Area, Res Triangle Pk, NC USA
来源：
PNEUMOLOGIE | 2021年 / 75卷
基金：
芬兰科学院;
关键词：
D O I：
10.1055/s-0041-1723351
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P724
引用
收藏
页码：S46 / S47
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
    Roufosse, Florence
    Kahn, Jean-Emmanuel
    Rothenberg, Marc E.
    Wardlaw, Andrew J.
    Klion, Amy D.
    Kirby, Suyong Yun
    Gilson, Martyn J.
    Bentley, Jane H.
    Bradford, Eric S.
    Yancey, Steven W.
    Steinfeld, Jonathan
    Gleich, Gerald J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (06) : 1397 - 1405
  • [2] Efficacy and Safety of Mepolizumab in Hypereosinophilic Syndrome: A Phase Ill, Randomized, Placebo-Controlled Trial
    Steinfeld, J.
    Rofousse, F.
    Kahn, J.
    Gleich, G.
    Rothenberg, M.
    Wardlaw, A.
    Kirby, S. Yun
    Gilson, M.
    Bentley, J.
    Bradford, E. S.
    Yancey, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [3] A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
    Lewiecki, E. Michael
    Blicharski, Tomasz
    Goemaere, Stefan
    Lippuner, Kurt
    Meisner, Paul D.
    Miller, Paul D.
    Miyauchi, Akimitsu
    Maddox, Judy
    Chen, Li
    Horlait, Stephane
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (09): : 3183 - 3193
  • [4] Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
    Wechsler, M. E.
    Akuthota, P.
    Jayne, D.
    Khoury, P.
    Klion, A.
    Langford, C.
    Merkel, P. A.
    Moosig, F.
    Specks, U.
    Cid, M. C.
    Luqmani, R.
    Brown, J.
    Mallett, S.
    Philipson, R.
    Yancey, S.
    Steinfeld, J.
    Weller, P. F.
    Gleich, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [5] Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial
    Chen, Ruchong
    Wei, Liping
    Dai, Yuanrong
    Wang, Zaiyi
    Yang, Danrong
    Jin, Meiling
    Xiong, Cui
    Li, Ting
    Hu, Shuling
    Song, Jie
    Chan, Robert
    Kumar, Subramanya
    Abdelkarim, Azza
    Zhong, Nanshan
    [J]. ERJ OPEN RESEARCH, 2024, 10 (03)
  • [6] Efficacy and Safety of Pregabalin in the Treatment of Alcohol Withdrawal Syndrome: A Randomized Placebo-Controlled Trial
    Foerg, Anna
    Hein, Jakob
    Volkmar, Katharina
    Winter, Martin
    Richter, Christoph
    Heinz, Andreas
    Mueller, Christian A.
    [J]. ALCOHOL AND ALCOHOLISM, 2012, 47 (02): : 149 - 155
  • [7] Efficacy and safety of abatacept in active primary Sjogren's syndrome: results of a phase III, randomised, placebo-controlled trial
    Baer, Alan N.
    Gottenberg, Jacques-Eric
    St Clair, E. William
    Sumida, Takayuki
    Takeuchi, Tsutomu
    Seror, Raphaele
    Foulks, Gary
    Nys, Marleen
    Mukherjee, Sumanta
    Wong, Robert
    Ray, Neelanjana
    Bootsma, Hendrika
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03) : 339 - 348
  • [8] EFFICACY AND SAFETY OF ABATACEPT IN ACTIVE PRIMARY SJOGREN'S SYNDROME: RESULTS OF A RANDOMISED PLACEBO-CONTROLLED PHASE III TRIAL
    Baer, Alan
    Gottenberg, Jacques-Eric
    St Clair E, William
    Sumida, Takayuki
    Takeuchi, Tsutomu
    Seror, Raphaele
    Foulks, Gary
    Nys, Marleen
    Johnsen, Alyssa
    Wong, Robert
    Ray, Neelanjana
    Bootsma, Hendrika
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 89 - 90
  • [9] Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial
    Kimball, Alexa B.
    Prens, Errol P.
    Passeron, Thierry
    Maverakis, Emanual
    Turchin, Irina
    Beeck, Stefan
    Drogaris, Leonidas
    Geng, Ziqian
    Zhan, Tianyu
    Messina, Izabella
    Bechara, Falk G.
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (05) : 1099 - 1111
  • [10] Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis
    Chmiel, James F.
    Flume, Patrick
    Downey, Damian G.
    Dozor, Allen J.
    Colombo, Carla
    Mazurek, Henryk
    Sapiejka, Ewa
    Rachel, Marta
    Constantine, Scott
    Conley, Brian
    Dgetluck, Nancy
    Dinh, Quinn
    White, Barbara
    Elborn, J. Stuart
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) : 78 - 85
12345